Department of Obstetrics and Gynecology, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing.
Eur J Histochem. 2022 Sep 2;66(3):3438. doi: 10.4081/ejh.2022.3438.
Long non-coding RNA WAC antisense RNA 1 (lncRNA WAC-AS1) is involved in the replication of the hepatitis B virus (HBV). The purpose of this study was to determine its functions and specific mechanism. The levels of lncRNA WAC-AS1, RNA (miR)-192-5p and were examined in serum of HBV-infected patients and in HepG2.2.15 cells using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blotting. Using the database starBase, the target binding sites of lncRNA WAC-AS1 and miR-192-5p were predicted and confirmed by dual-luciferase reporter assay and RNA pull-down assay. The expression of pgRNA and HBV DNA was determined by qRT-PCR, while the levels of HBeAg and HBsAg were measured by enzyme-linked immunosorbent assay (ELISA). Using laser scanning confocal microscopy, the light chain 3 (LC3) expression was analyzed. qRT-PCR and Western blotting were used to assess the expression of beclin-1, p62, and LC3I/II. Overexpression of lncRNA WAC-AS1, upregulation of ATG7. and downregulation of miR-192-5p were observed in the serum of HBV-infected patients and the in vitro model. miR-192-5p directly targets lncRNA WAC-AS1. LncRNA WAC-AS1 was downregulated in lncRNA WAC-AS1-shRNA‒transfected cells. miR-192-5p was upregulated in lncRNA WAC-AS1-shRNA-transfected cells and downregulated in cells transfected with a miR-192-5p inhibitor. In HepG2 2.15 cells, the downregulation of lncRNA WAC-AS1 inhibited HBV replication and autophagy. In contrast, the miR-192-5p inhibitor-transfected group exhibited the opposite results, and ATG7 overexpression reversed the effects of miR-192-5p mimic or lncRNA WAC-AS1-shRNA on HBV replication and cell autophagy. Our findings indicate that lncRNA WAC-AS1 regulates HBV replication by reinforcing the autophagy induced by miR-192-5p/ATG7. Consequently, lncRNA WAC-AS1 may serve as a therapeutically-promising target in HBV patients.
长链非编码 RNA WAC 反义 RNA 1(lncRNA WAC-AS1)参与乙型肝炎病毒(HBV)的复制。本研究旨在确定其功能和具体机制。采用实时定量逆转录聚合酶链反应(qRT-PCR)和 Western blot 检测乙型肝炎病毒感染者血清及 HepG2.2.15 细胞中 lncRNA WAC-AS1、RNA(miR)-192-5p 和的水平。使用数据库 starBase,通过双荧光素酶报告基因检测和 RNA 下拉实验预测和验证 lncRNA WAC-AS1 和 miR-192-5p 的靶结合位点。通过 qRT-PCR 检测 pgRNA 和 HBV DNA 的表达,通过酶联免疫吸附试验(ELISA)检测 HBeAg 和 HBsAg 的水平。采用激光共聚焦显微镜分析 LC3 表达。通过 qRT-PCR 和 Western blot 检测 beclin-1、p62 和 LC3I/II 的表达。在乙型肝炎病毒感染者的血清和体外模型中观察到 lncRNA WAC-AS1 过表达、ATG7 上调和 miR-192-5p 下调。miR-192-5p 直接靶向 lncRNA WAC-AS1。lncRNA WAC-AS1 在 lncRNA WAC-AS1-shRNA 转染细胞中下调。lncRNA WAC-AS1-shRNA 转染细胞中 miR-192-5p 上调,miR-192-5p 抑制剂转染细胞中 miR-192-5p 下调。在 HepG2.2.15 细胞中,下调 lncRNA WAC-AS1 抑制 HBV 复制和自噬。相反,miR-192-5p 抑制剂转染组则表现出相反的结果,并且 ATG7 过表达逆转了 miR-192-5p 模拟物或 lncRNA WAC-AS1-shRNA 对 HBV 复制和细胞自噬的影响。我们的研究结果表明,lncRNA WAC-AS1 通过增强 miR-192-5p/ATG7 诱导的自噬来调节 HBV 复制。因此,lncRNA WAC-AS1 可能成为乙型肝炎病毒患者有治疗前景的靶点。